Bruce Maches provides a thorough examination of the complexity and resource requirements of specialized life science applications and what the role (and challenges) will be as cloud continue to enter into the industry. Many life science companies are struggling to afford to internally build, implement, and support much of the required systems and infrastructure but as Maches argues, there are alternatives.
We recently published an article that provided the opinions of a number of thought and industry leaders on the subject of public cloud viability for mission-critical or business-critical needs. While the responses were rather wide-ranging, there were a few common issues (including matters of cost, security and existing investment) that got Robin Meehan’s wheels turning.
Making sense of private cloud ROI is tricky business; for some, private clouds are a no-brainer following even a cursory cost analysis, for others this is never quite clear—just how much will be saved with an investment now (despite constrained budgets) over the course of say, five years—and will it be worth it?
While private clouds are getting far more attention than they received at the beginning of the cloud buzz boom, the realities of the complexities of actual building them–not to mention the financial and time investments–are often overlooked.